Almost running the table

Almost running the table

Company 1Q04EPS est 1Q04EPS actual Outcome Growth from 1Q03 4/30cls Wk chg %chg Mcap chg 4/30Mcap
Actelion NA CHF1.27 NA 568% CHF142.25 CHF5.75 4% $92.3 $2,400.0
Sales of pulmonary arterial hypertension (PAH) drug Tracleer increased 60% to CHF97.1M from CHF60.7M in the same period last year.
Applied Biosystems $0.21 $0.21 Met 11% $18.57 ($0.83) -4%

Read the full 654 word article

How to gain access

Continue reading with a
two-week free trial.